Total Payments
$16,239
2024 Payments
$1,627
Companies
42
Transactions
825
Medicare Patients
2,371
Medicare Billing
$245,959
Payment Breakdown by Category
Food & Beverage$16,209 (99.8%)
Education$29.78 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,209 | 821 | 99.8% |
| Education | $29.78 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,920 | 188 | $0 (2024) |
| Novo Nordisk Inc | $2,262 | 116 | $0 (2024) |
| Lilly USA, LLC | $1,546 | 99 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,348 | 65 | $0 (2024) |
| Merck Sharp & Dohme LLC | $892.30 | 55 | $0 (2023) |
| PFIZER INC. | $789.10 | 51 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $705.75 | 37 | $0 (2024) |
| ABBVIE INC. | $647.75 | 32 | $0 (2024) |
| Amgen Inc. | $620.29 | 21 | $0 (2023) |
| Esperion Therapeutics, Inc. | $498.55 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,627 | 73 | AstraZeneca Pharmaceuticals LP ($523.02) |
| 2023 | $2,281 | 106 | AstraZeneca Pharmaceuticals LP ($640.72) |
| 2022 | $2,485 | 117 | AstraZeneca Pharmaceuticals LP ($553.04) |
| 2021 | $2,164 | 104 | AstraZeneca Pharmaceuticals LP ($474.66) |
| 2020 | $1,651 | 95 | AstraZeneca Pharmaceuticals LP ($381.13) |
| 2019 | $2,019 | 115 | AstraZeneca Pharmaceuticals LP ($431.34) |
| 2018 | $2,058 | 107 | Novo Nordisk Inc ($527.74) |
| 2017 | $1,953 | 108 | AstraZeneca Pharmaceuticals LP ($553.93) |
All Payment Transactions
825 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Oncology | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Insomnia | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $27.16 | General |
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Obesity | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 09/20/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 678 | 929 | $121,034 | $61,917 |
| 2022 | 13 | 700 | 954 | $143,729 | $75,702 |
| 2021 | 7 | 544 | 773 | $117,419 | $58,809 |
| 2020 | 10 | 449 | 659 | $115,428 | $49,531 |
Total Patients
2,371
Total Services
3,315
Medicare Billing
$245,959
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 161 | 345 | $52,785 | $24,980 | 47.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 111 | 111 | $26,640 | $16,388 | 61.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 62 | 62 | $10,726 | $4,951 | 46.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 60 | 60 | $4,500 | $4,333 | 96.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 66 | $14,718 | $3,758 | 25.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 15 | $3,750 | $3,430 | 91.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 62 | $3,224 | $2,195 | 68.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 116 | 166 | $2,324 | $705.60 | 30.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $1,316 | $582.34 | 44.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 13 | $676.00 | $467.74 | 69.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 15 | $375.00 | $126.00 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 248 | $55,304 | $26,093 | 47.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 114 | 114 | $27,360 | $17,556 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 231 | $35,343 | $16,821 | 47.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 44 | 44 | $3,300 | $3,091 | 93.7% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $4,308 | $3,021 | 70.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $3,740 | $2,203 | 58.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 27 | 27 | $4,671 | $2,086 | 44.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 56 | 56 | $2,912 | $1,978 | 67.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 15 | $2,295 | $1,326 | 57.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 18 | $936.00 | $640.26 | 68.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 73 | 88 | $1,232 | $419.02 | 34.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 12 | 13 | $403.00 | $239.46 | 59.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 67 | 77 | $1,925 | $228.36 | 11.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 194 | $43,262 | $19,220 | 44.4% |
About Neil Nepola, MDPC
Neil Nepola, MDPC is a Family Medicine healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942261177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Neil Nepola, MDPC has received a total of $16,239 in payments from pharmaceutical and medical device companies, with $1,627 received in 2024. These payments were reported across 825 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($16,209).
As a Medicare-enrolled provider, Nepola has provided services to 2,371 Medicare beneficiaries, totaling 3,315 services with total Medicare billing of $245,959. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Staten Island, NY
- Active Since 03/29/2006
- Last Updated 09/03/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942261177
Products in Payments
- FARXIGA (Drug) $1,623
- TRULICITY (Drug) $969.52
- Ozempic (Drug) $944.50
- BREZTRI (Drug) $741.68
- VRAYLAR (Drug) $667.04
- SYMBICORT (Drug) $647.97
- JANUVIA (Drug) $585.86
- TRELEGY ELLIPTA (Drug) $583.89
- TRINTELLIX (Drug) $557.36
- NURTEC ODT (Drug) $528.58
- NEXLETOL (Drug) $481.23
- FASENRA (Biological) $374.99
- Victoza (Drug) $321.41
- ANORO (Drug) $312.10
- Rybelsus (Drug) $290.76
- Aimovig (Biological) $289.34
- MOUNJARO (Drug) $204.59
- CHANTIX (Drug) $202.39
- TUDORZA PRESSAIR (Drug) $197.71
- Crysvita (Drug) $197.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Staten Island
Dr. Sean Fenton, Do, DO
Family Medicine — Payments: $151,500
Family Medicine $151,500
Rena Khanukayeva
Family Medicine — Payments: $18,496
Family Medicine $18,496
Dr. Joseph Buono, Md, MD
Family Medicine — Payments: $17,313
Family Medicine $17,313
Dr. Arthur Sigelman, M.d, M.D
Family Medicine — Payments: $16,837
Family Medicine $16,837
Dr. Tatyana Katsman, D.o, D.O
Family Medicine — Payments: $11,356
Family Medicine $11,356
Dr. Tauqeer Ahmad, Md, MD
Family Medicine — Payments: $4,099
Family Medicine $4,099